Throughout this medical market research, the publisher analyzed 46 interventional cardiology companies across Europe and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this MedSuite report contains all of EU Interventional Cardiology Device Market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes an interventional cardiology procedure volume analysis which can also be purchased as a separate report, MedPro.
Markets Covered
EU Interventional Cardiology Device Market Insights
Due to COVID19, the European Interventional Cardiology market size declined by almost 27% from 2019, resulting in a valuation of approximately €928 million in 2020. The market size is expected to return to pre-COVID19 levels in 2022, and reach €1 billion in 2026.
Technologies such as computer tomography (CT), optical coherence tomography (OCT), and magnetic resonance imaging (MRI) are becoming more efficient at diagnosing cardiovascular diseases. These higher-resolution technologies are expected to be better at identifying cardiovascular disease during the first procedure, negating the need for a second procedure and limiting the total number of diagnostic procedures performed. Prices for these image-guided devices are much higher than traditional interventional devices, resulting in upwards pressure on market value.
Boston Scientific was the leading competitor in the European market for interventional cardiology devices in 2020. The company was the leader of several segments, including coronary stents, balloon catheters, embolic protection devices, and atherectomy devices.
Report Regional Coverage
Throughout this research series, the publisher has covered several countries in great detail. The countries covered are:
While this MedSuite report contains all of EU Interventional Cardiology Device Market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes an interventional cardiology procedure volume analysis which can also be purchased as a separate report, MedPro.
Markets Covered
- Procedure Volumes for the Interventional Cardiology Market in Europe - MedPro
- Coronary Stent Market - MedCore
- Coronary Balloon Catheter Market - MedCore
- Interventional Coronary Catheter Market - MedCore
- Interventional Coronary Guidewire Market - MedCore
- Coronary Embolic Protection Device Market - MedCore
- Coronary Atherectomy Device Market - MedCore
- Introducer Sheath Market - MedCore
- Coronary Vascular Closure Device (VCD) Market - MedCore
- Diagnostic Coronary Catheter & Guidewire Market - MedCore
- Coronary Intravascular Ultrasound (IVUS) Market - MedCore
- Coronary Optical Coherency Tomography Market - MedCore
EU Interventional Cardiology Device Market Insights
Due to COVID19, the European Interventional Cardiology market size declined by almost 27% from 2019, resulting in a valuation of approximately €928 million in 2020. The market size is expected to return to pre-COVID19 levels in 2022, and reach €1 billion in 2026.
Technologies such as computer tomography (CT), optical coherence tomography (OCT), and magnetic resonance imaging (MRI) are becoming more efficient at diagnosing cardiovascular diseases. These higher-resolution technologies are expected to be better at identifying cardiovascular disease during the first procedure, negating the need for a second procedure and limiting the total number of diagnostic procedures performed. Prices for these image-guided devices are much higher than traditional interventional devices, resulting in upwards pressure on market value.
Boston Scientific was the leading competitor in the European market for interventional cardiology devices in 2020. The company was the leader of several segments, including coronary stents, balloon catheters, embolic protection devices, and atherectomy devices.
Report Regional Coverage
Throughout this research series, the publisher has covered several countries in great detail. The countries covered are:
- Germany
- France
- U.K.
- Italy
- Spain
- Benelux (Belgium, Netherlands, and Luxembourg)
- Scandinavia (Denmark, Finland, Norway, and Sweden)
- Switzerland
- Austria
- Portugal
Table of Contents
TABLE OF CONTENTS
RESEARCH METHODOLOGY
IMPACT OF COVID-19 ON THE EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICE MARKET
DISEASE OVERVIEW
PRODUCT ASSESSMENT
EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICE MARKET OVERVIEW
COUNTRY PROFILES
PROCEDURE NUMBERS
CORONARY STENT MARKET
CORONARY BALLOON CATHETER MARKET
INTERVENTIONAL CORONARY CATHETER MARKET
INTERVENTIONAL CORONARY GUIDEWIRE MARKET
CORONARY EMBOLIC PROTECTION DEVICE MARKET
CORONARY ATHERECTOMY DEVICE MARKET
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott
- ACIST Medical Systems
- Acrostak
- Alvimedia
- AndraTec
- AngioDynamics
- Argon Medical
- Asahi Intecc
- B. Braun
- Balton Medical
- Becton Dickinson
- Biosensors
- Biotronik
- Boston Scientific
- Cardinal Health
- Cardiovascular Systems Inc.
- Cardiovovum
- Cardiva
- CeloNova BioSciences
- Comed
- Contego Medical
- Cook Medical
- Elixir Medical Corporation
- Eucatech
- Euocor
- Galt Medical
- Hexacath
- iVascular
- Kardia
- Kimal
- Medcomp
- Medtronics
- Meril Life Sciences
- Merit Medical
- Opsens
- OrbusNeich
- Philips
- Rontis
- Simeks Medical
- SMT
- Stentys
- Teleflex
- Terumo
- Vascular Perspectives
- Vasorum
- Wellinq
